Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PRCY - ANY BODY HAS ANY NEWS ON THESE -- Ignore unavailable to you. Want to Upgrade?

To: Vip who wrote (411)	11/4/1998 12:26:00 PM
From: Douglas	Read Replies (2) \| Respond to of 670

ProCyte Signs Supply Agreement for Skin Care Targets Rapidly Growing Aesthetic Surgery Market REDMOND, Wash., Nov. 4 /PRNewswire/ -- ProCyte Corporation (Nasdaq: PRCY - news) said closely held AdvoCare, Inc. will supply ProCyte's skin care products to patients undergoing cosmetic and aesthetic surgery. AdvoCare will market, finance and provide pre- and post-operative care for cosmetic and aesthetic surgery procedures. The company has developed a comprehensive package of products and services which address the needs of physicians and patients through all aspects of cosmetic surgery, beginning with the initial consultation. The non-exclusive agreement gives ProCyte additional access to this niche marketplace for its full line of products, including patient kits specifically designed for AdvoCare and its physician customers. The initial product launch will focus on laser skin resurfacing procedures, and will feature ProCyte's new line of Complex Cu3(TM) products including Tissue Repair Creme, Gel and Cleanser, packaged in a post-laser kit. Based on ProCyte's patented copper peptide technology, Complex Cu3(TM) products represent a significant advance for post-laser recovery by promoting an optimal healing environment. Plans call for a launch of the promotional programs during early 1999 and participation by over 1300 of the largest physician offices during the first two years. ProCyte will begin shipping orders in 1999. This report may contain forward looking statements. The Company's results may vary significantly from quarter to quarter and will depend among other factors on product launches and market acceptance, manufacturing contracts, and distribution agreements. ProCyte Corporation is a healthcare company that develops, manufactures and markets products for tissue repair, skin health and hair care. The Company's products incorporate its patented copper peptide technology and are marketed both directly and through distribution partners.